Log In
Print this Print this

Ultresa, pancrelipase

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionDelayed-release pancrelipase formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency due to cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today